1295 Stock Overview
Engages in the research and manufacture of probiotics. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Synbio Tech Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$72.90 |
| 52 Week High | NT$93.00 |
| 52 Week Low | NT$62.25 |
| Beta | 0 |
| 1 Month Change | -10.00% |
| 3 Month Change | -20.33% |
| 1 Year Change | -6.23% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -4.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1295 | TW Biotechs | TW Market | |
|---|---|---|---|
| 7D | -4.1% | 1.7% | 0.3% |
| 1Y | -6.2% | 2.1% | 27.4% |
Return vs Industry: 1295 underperformed the TW Biotechs industry which returned 2.1% over the past year.
Return vs Market: 1295 underperformed the TW Market which returned 27.4% over the past year.
Price Volatility
| 1295 volatility | |
|---|---|
| 1295 Average Weekly Movement | 3.6% |
| Biotechs Industry Average Movement | 4.5% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 1295 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 1295's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | n/a | n/a | www.synbiotech.com |
Synbio Tech Inc. engages in the research and manufacture of probiotics. The company provides SynForU-MemoryUp, a solution for brain health; Lactobacillus plantarum TWK10 for exercise performance; ABKEFIR to improve digestive and promote human health; SynForU-ImmuUp for immune system; SynForU-GastroKeep, a stomach care probiotic; SynForU-HepaAid, a liver care probiotic; SynForU-HerCare, which inhibit the growth of fungal and bacterial pathogens, and maintain the vaginal microbiome in proper balance; SynForU-Remain, a kidney care solution; and multi strain probiotics. Its single probiotics strain includes bacillus coagulans, bifidobacterium animalis subsp.
Synbio Tech Inc. Fundamentals Summary
| 1295 fundamental statistics | |
|---|---|
| Market cap | NT$2.35b |
| Earnings (TTM) | NT$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 1295 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1295 income statement (TTM) | |
|---|---|
| Revenue | NT$0 |
| Cost of Revenue | NT$0 |
| Gross Profit | NT$0 |
| Other Expenses | NT$0 |
| Earnings | NT$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 1295 perform over the long term?
See historical performance and comparisonDividends
2.0%
Current Dividend Yieldn/a
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 13:55 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | N/A |
| Annual Earnings | N/A |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Synbio Tech Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|